ARMANI: Ramucirumab Plus Paclitaxel as Switch Maintenance for Advanced HER2-Negative Gastric Cancer

(4:3)

ARMANI: ramucirumab + paclitaxel vs continuation of chemo in advanced HER2- gastric or GEJ cancer

(2:52)

ARMANI: switch maintenance with ramucirumab \u0026 paclitaxel in G/GEJ cancer

(56)

Dr.Filippo Pietrantonio on ARMANI Trial Findings for Advanced Gastric Cancer | ASCO 2024

(3:41)

Adverse effects of ramucirumab plus paclitaxel for HER2- G/GEJ cancer

(32)

Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advance...

(5:11)

Romane gila Armani 2017 -Te awilanas jek aswin , Ando parko

(6:10)

Interview with Rose Roes about Non Duality, by Hellmut Monz ( Vietnam), Oct 2024

(43:12)

|| Webinar - Lessons from ASCO 2024 DEEP DIVE GI Cancers || 11th July 2024 ||

(2:19:37)

ASCO 2024 and ESMO GI 2024 Updates Webinar | Feat. Dr. Samuel Klempner

(1:3:54)

RomaneGila Dunya 2016 Bagel Dzeremi\u0026Malencio

(4:57)

Romane Gila Armani 2017!! NEW !!

(1:24)

Romane gila armani 2018wowi

(1:46)

My Way

(3:42)

GI Abstracts at #ASCO23 by Dr. Kathrin Heinrich

(2:9)

Romane gila armani 2017 orginal

(3:29)

GI CONNECT Update from ASCO 2024

(8:19)

GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis

(27:17)

Standard-of-Care, Second-Line, and Future Therapies for GEJ and Esophageal Adenocarcinoma

(20:50)

CROSS vs. PeriOp FLOT - ESOPEC Study

(58)

ASCO 2024: What the ESOPEC, RENAISSANCE, and ARMANI Trials Mean for the Future of Esophageal Canc...

(19:37)

Ablation or Surgery for small liver metastatic colorectal cancer: COLLISON Trial

(32)

TRAILER : GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis

(54)

A Feast Of Updates

(17:6)

ROMANE GILA 2017 ARMANI

(1:39)

Clinical Scenarios and Approaches to Treating Locally Advanced Esophageal Adenocarcinoma

(19:28)

Updates in the Management of Metastatic Gastroesophageal Cancer | Saurin Chokshi, MD

(25:31)